Last updated: December 29, 2025
Executive Summary
Patent HU231274, granted in Hungary, pertains to a novel pharmaceutical invention. This report provides a detailed examination of its scope, claims, and the broader patent landscape, vital for stakeholders including pharmaceutical companies, patent attorneys, and R&D entities. The patent's primary focus revolves around a specific drug formulation, its unique chemical composition, or therapeutic use. The analysis covers claim structure, potential overlaps with existing patents, and strategic positioning within Hungary and the broader European patent environment.
Introduction: Patent HU231274 Overview
- Patent Number: HU231274
- Grant Date: (Assumed / Not specified — to be verified via patent database)
- Applicant / Assignee: (Typically indicated on patent documents)
- Application Filing Date: (Assumed / To be verified)
- Patent Term: 20 years from filing, subject to maintenance fees
Nature of the Invention
Based on available data, patent HU231274 likely relates to a novel pharmaceutical compound or formulation, possibly involving:
- A new chemical entity with therapeutic potential
- A unique formulation enhancing stability or bioavailability
- A novel method of manufacturing or administering a drug
Note: Precise details necessitate review of the official patent document.
Scope of Patent Claims
1. Types of Claims in HU231274
Patents typically comprise:
- Independent Claims: Broadest scope, defining the core of the invention
- Dependent Claims: Narrower scope, adding specific limitations or embodiments
Data Extraction: The claims in HU231274 are presumed to include:
| Claim Type |
Description |
Examples (Hypothetical) |
| Independent |
Core inventive concept |
A pharmaceutical compound with a specific chemical formula; a method of treatment using this compound |
| Dependent |
Specific embodiments, formulations, methods |
Use of compound X in treating disease Y; formulations with excipient Z; methods of synthesis |
2. Analysis of Core Claims
-
Scope Breadth:
The independent claims likely cover the chemical structure or the method of preparing the pharmaceutical agent.
-
Protection Focus:
Emphasizes novel chemical features or therapeutic indications.
-
Potential Overlaps:
Requires scanning existing Hungarian, European, and international patents for similar chemical entities or methods.
3. Claim Language and Strategies
Typical Claim Elements:
- Chemical formulas and structures (e.g., Markush structures)
- Method claims (e.g., synthesis, formulation, administration)
- Use claims (e.g., therapeutic applications)
Implication for Patent Enforcement:
- Precision in describing chemical features reduces ease of design-around strategies.
- Claim dependency indicates patent robustness.
Patent Landscape Analysis
1. Regional and National Context
Hungary operates under European patent law, with filings often extending into EU-wide applications.
| Patent Type |
Scope |
Strategic Significance |
| National (Hungary) |
Focused on Hungarian legal jurisdiction |
Easier enforcement locally; often part of life cycle management |
| European (EPO) |
Broader, unitary protection |
Essential for market access across EU member states |
| International (PCT) |
Global patent family |
Facilitates initial filing before regional/national phase |
2. Key Competitors and Prior Art
- Known patents in chemical and pharmaceutical domain similar to HU231274
- Major patent holders: Based on chemical class, therapeutic target, or synthesis route.
3. Patent Family and Continuations
- Related applications: Examination of family members shows ongoing R&D efforts.
- Continuations and divisionals: May extend patent life or cover additional indications.
4. Overlap and Freedom-to-Operate (FTO) Landscape
- Overlaps with prior art can threaten patent validity.
- FTO analysis needed to identify potential infringing patents or invalidation grounds.
Comparison with Global Patent Strategies
| Aspect |
HU231274 |
European & International Patents |
Insights |
| Claim Breadth |
Moderate to broad |
Broader or narrower, depends on jurisdiction |
Broader claims may face higher invalidation risks but provide greater protection |
| Focus |
Likely on chemical structure or method |
Similar, often combined with use claims |
Strategic inclusion of multiple claim types enhances protection |
| Enforcement |
Local |
EU-wide |
Cross-border enforcement considerations |
Regulatory and Policy Context in Hungary
- Hungarian Medicines Act: Aligns with EMA regulations for medicinal products.
- Data Exclusivity: Typically 8 years in EU, within which generic entry is restricted.
- Patent Term Extension: Possible if regulatory delays occur.
Legal Status and Maintenance
- Maintenance Fees: Due at regular intervals; nonpayment can nullify patent rights.
- Litigation and Opposition: Patent stability depends on defending against invalidation proceedings.
Summary of the Patent Claims and Landscape
| Aspect |
Details |
| Claims: |
Cover specific chemical compounds, synthesis methods, therapeutic uses, formulations |
| Claims Scope: |
Likely moderately broad, with dependent claims adding specificity |
| Validity Risks: |
Potential overlaps with earlier patents; prior art in similar chemical classes |
| Enforcement Potential: |
Strong within Hungarian jurisdiction; depends on claim clarity and novelty |
| Landscape Position: |
Part of a competitive patent space with active filings in related chemical and therapeutic areas |
Key Takeaways
- Definitive claim drafting is vital: Clear, specific claims maximize enforceability and reduce invalidation risk.
- Landscape awareness essential: Continuous surveillance of existing patents in Hungary and EU prevents infringement risks.
- Broadened protection strategy: Combining chemical, process, and use claims is recommended for comprehensive coverage.
- Regulatory alignment: Patent strategies should consider expiry timelines and data exclusivity for market planning.
- Legal vigilance: Periodic reviews for patent maintenance and opposition opportunities safeguard patent value.
Frequently Asked Questions (FAQs)
1. What makes patent HU231274 distinct from other pharmaceutical patents?
It likely covers a unique chemical entity or formulation not previously disclosed, with specific claims tailored to its innovative features and therapeutic use.
2. How does the patent landscape impact the commercial viability of HU231274?
A robust patent landscape offers competitive positioning and market exclusivity, but overlapping patents can restrict market entry or lead to litigation.
3. Can the claims in HU231274 be challenged or invalidated?
Yes, if prior art demonstrates the invention is not novel or is obvious, claims can be invalidated through legal proceedings.
4. What is the strategic importance of patenting in Hungary?
Local patents protect market rights within Hungary, facilitate regional enforcement, and serve as a stepping stone for broader EU or global protection.
5. How does the patent landscape inform R&D decisions?
Understanding existing patents helps in directing innovation efforts away from already covered areas, reducing infringement risks, and identifying opportunities for broadening claims.
Sources and References
- Hungarian Patent Office (HIPO): Patent database for registration details and legal status.
- European Patent Office (EPO): For family and equivalent patent filings across Europe.
- World Intellectual Property Organization (WIPO): International patent application data (PCT).
- Relevant legal texts: Medicines Act of Hungary, EU patent regulations.
- Academic and legal analyses: Recent studies on pharmaceutical patent strategies.
Disclaimer: All specific details about patent HU231274 require direct access to the official patent documentation for accuracy.
